_0.png)
For immediate release – September 2, 2021
Halifax -IWK Health is reporting the first use of high dose ibuprofen in North America to treat patent ductus arteriosus (PDA) a common heart problem which occurs most often in extremely premature infants. In a paper published in the Journal of Perinatology the treatment shows a 21 per cent reduction in the need for the risky heart surgery.
Continue ReadingFor immediate release – August 20, 2021
Continue ReadingHalifax - Researchers at IWK Health, in partnership with leading vaccine and infectious diseases researchers, have found that maternal influenza vaccination during pregnancy is not significantly associated with an increased risk of adverse early childhood health outcomes. Continue Reading
IWK Health is respected for its world-class research into disorders and diseases affecting women, children, youth and families and is home to many leading research centres.
Learn more about our research centres by visiting one of the links below.
Book Online